SO
TXMD icon

STRS Ohio’s TherapeuticsMD TXMD Stock Holding History

STRS Ohio’s Portfolio TXMD Stock Details TXMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-964
Closed -$329K – 1936
2015
Q4 		$499K Sell
964
-1,519
-61% -$561K ﹤0.01% 1282
2015
Q3 		$727K Buy
2,483
+1,609
+184% +$572K ﹤0.01% 1011
2015
Q2 		$343K Hold
874
– – ﹤0.01% 1442
2015
Q1 		$264K Buy
874
+130
+17% +$31.7K ﹤0.01% 1398
2014
Q4 		$166K Sell
744
-478
-39% -$98.6K ﹤0.01% 1476
2014
Q3 		$284K Sell
1,222
-56
-4% -$14.1K ﹤0.01% 1372
2014
Q2 		$282K Buy
+1,278
New +$284K ﹤0.01% 1383
2013
Q4 		– Sell
-546
Closed -$80K – 1820
2013
Q3 		$80K Sell
546
-182
-25% -$22K ﹤0.01% 1674
2013
Q2 		$110K Buy
+728
New +$99.7K ﹤0.01% 1614

Other funds holding TXMD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GGHC
Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

STRS Ohio's TXMD Position: Q1 2016 in Review

STRS Ohio sold out of TherapeuticsMD (TXMD) in Q1 2016, closing a stake of 964 shares — an estimated $329K sold.

STRS Ohio first reported a position in TXMD in Q2 2013 and held it in 9 quarters. The position peaked at $727K in Q3 2015. 128 funds tracked by Wall St. Rank hold TXMD as of Q1 2016.

  • STRS Ohio reported no remaining TherapeuticsMD position as of Q1 2016 after selling out during the quarter.
  • STRS Ohio sold 964 TherapeuticsMD shares in Q1 2016, an estimated $329K.
  • STRS Ohio first reported a position in TherapeuticsMD in Q2 2013 and held it in 9 quarters.
  • STRS Ohio's TherapeuticsMD position peaked at $727K in Q3 2015.
  • 128 funds tracked by Wall St. Rank held TherapeuticsMD as of Q1 2016.

Based on STRS Ohio's 13F filing for Q1 2016, filed 21 Apr 2016.